Matthew Winton

Companies

• CervoMed Inc.Chief Commercial and Business Oct 8, 2025 to now¹
• Inozyme Pharma, Inc.Chief operating officer Apr 4, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CCervoMed Inc. CRVO15,000 shares³$33.6K at $2.24Nov 18, 2025
• IPInozyme Pharma, Inc.0 shares⁴Jul 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 18, 2025Bought 1,500 shares at $7.95 of CervoMed Inc.³
• Nov 17, 2025Bought 3,500 shares at $8.43 of CervoMed Inc.³
• Nov 14, 2025Bought 10,000 shares at $7.57 of CervoMed Inc.⁵
• Jul 1, 2025U 21,743 shares at $4.00 of Inozyme Pharma, Inc.⁴
• Jun 25, 2025Granted 14,355 shares at $0.74 of Inozyme Pharma, Inc.⁶
• Mar 31, 2025Granted 2,490 shares at $0.77 of Inozyme Pharma, Inc.⁷
• Sep 30, 2024Granted 1,710 shares at $4.45 of Inozyme Pharma, Inc.⁸
• Mar 28, 2024Granted 3,188 shares at $3.33 of Inozyme Pharma, Inc.⁹